CN Patent

CN116669710A — 白介素-23受体的肽抑制剂的组合物

Assigned to Janssen Pharmaceutica NV · Expires 2023-08-29 · 3y expired

What this patent protects

本发明涉及白介素‑23受体(IL‑23R)的肽抑制剂或者其药学上可接受的盐或溶剂化物形式的组合物、对应药物组合物、用于治疗自身免疫性炎症以及相关疾病和障碍的方法和/或用途。

USPTO Abstract

本发明涉及白介素‑23受体(IL‑23R)的肽抑制剂或者其药学上可接受的盐或溶剂化物形式的组合物、对应药物组合物、用于治疗自身免疫性炎症以及相关疾病和障碍的方法和/或用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN116669710A
Jurisdiction: CN
Classification: —
Expires: 2023-08-29
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Pharmaceutica NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.